Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is at present an
emerging global public health crisis. Angiotensin converting enzyme 2 (ACE2) and trans …

Background To mitigate the effects of COVID-19, a vaccine is urgently needed. BBV152 is a
whole-virion inactivated SARS-CoV-2 vaccine formulated with a toll-like receptor 7/8 agonist …

The rapid surge of SARS-CoV-2 cases due to the 'variant of concern (VOC) 202012/01', also
known as lineage B. 1.1. 7 or 20B/501Y. V1 in the UK, 1 in December 2020, raised concerns …

Over the last few years, the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
unleashed a global public health catastrophe that had a substantial influence on human …

The COVID-19 pandemic is a global health crisis that poses a great challenge to the public
health system of affected countries. Safe and effective vaccines are needed to overcome this …

This is a comprehensive report on immunogenicity of COVAXIN® booster dose against
ancestral and Variants of Concern (VOCs) up to 12 months. It is well known that neutralizing …

Methods: Publicly available data on type definitions based on whole-genome sequences of
the SARS-CoV-2 sampled during December and March 2020 from 3636 infected patients …

Currently, the world is witnessing the pandemic of COVID-19, a disease caused by the novel
coronavirus SARS-CoV-2. Reported differences in clinical manifestations and outcomes in …

Background A wide range of neurological manifestations has been described in COVID-19.
Methods In this nationwide retrospective observational study, patients in Tunisia diagnosed …

Humanity has seen numerous pandemics during its course of evolution. The list includes
several incidents from the past, such as measles, Ebola, severe acute respiratory syndrome …